Target intelligence / Profile preview

ABHD17A pseudogene 4 (ABHD17AP4)

Target: ABHD17AP4
Molecular classification: Other (Pseudogene)

Overview

ABHD17A pseudogene 4 (ABHD17AP4) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but nonfunctional; it does not encode an active protein product or have recognized biological activity in humans. It is also known by the aliases FAM108A5 and FAM108A5P[3]. No molecular function, disease association, or roles in signaling, drug interactions, or safety considerations have been described for this entity in available gene and functional databases[3][5][6]. The closely related gene ABHD17A is a protein-coding gene involved in protein depalmitoylation and various cellular processes[1][2][4], but ABHD17AP4 specifically is not a coding or therapeutic target by current definitions.

Other names: FAM108A5FAM108A5P[3]

Beyond the preview

Go deeper on ABHD17A pseudogene 4 (ABHD17AP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABHD17A pseudogene 4 (ABHD17AP4).

Explore the full profile